The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Khachatryan A.S.

Pirogov Russian National Research Medical University

Gusev L.L.

Pirogov Russian National Research Medical University;
Pirogov Moscow City Clinical Hospital No. 1

Khotinsky A.A.

Pirogov Russian National Research Medical University

An E.S.

Pirogov Russian National Research Medical University;
Pirogov Moscow City Clinical Hospital No. 1

Seliverstov E.I.

Pirogov Russian National Research Medical University;
Pirogov Moscow City Clinical Hospital No. 1

Outpatient Management of Venous Thromboembolism in Acute Phase

Authors:

Khachatryan A.S., Gusev L.L., Khotinsky A.A., An E.S., Seliverstov E.I.

More about the authors

Journal: Journal of Venous Disorders. 2024;18(4): 328‑338

Read: 1254 times


To cite this article:

Khachatryan AS, Gusev LL, Khotinsky AA, An ES, Seliverstov EI. Outpatient Management of Venous Thromboembolism in Acute Phase. Journal of Venous Disorders. 2024;18(4):328‑338. (In Russ.)
https://doi.org/10.17116/flebo202418041328

Recommended articles:
Postpartum gona­dal vein thro­mbosis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):72-78
Fibrin mono­mer in diagnosis of cardiovascular diseases. Russian Cardiology Bulletin. 2024;(4-2):113-120
Asplenia — a new cause of thro­mbosis in pregnant women?. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):71-76
Signs of high embo­lic risk in iliocaval floating thro­mbi. Piro­gov Russian Journal of Surgery. 2025;(3):56-62
Modern approach to the treatment of acute iliofemoral thro­mbosis. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(3):293-299
Thro­mboembolic complications in the postpartum period. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):102-107

References:

  1. Rossijskie klinicheskie rekomendacii po profilaktike i lecheniyu venoznyh tromboembolicheskih oslozhnenij (VTEO). Flebologiya. 2015;9(2):4-52. (In Russ.).
  2. The Vein Glossary. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2018;6(5):11-217.  https://doi.org/10.1016/j.jvsv.2018.08.001
  3. Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. Journal of Thrombosis and Thrombolysis. 2016;41(1):3-14.  https://doi.org/10.1007/s11239-015-1311-6
  4. Sazhin AV, Alenichev AV, An ES, Glyantsev SP. The Role of Saveliev V.S. and his School in Development of Endovascular Prevention of Pulmonary Embolism. Journal of Venous Disorders. 2024;18(1):6-12. (In Russ.). https://doi.org/10.17116/flebo2024180116
  5. Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA. Secular trends in occurrence of acute venous thromboembolism: The worcester VTE study (1985-2009). American Journal of Medicine. 2014;127(9):829-839.  https://doi.org/10.1016/j.amjmed.2014.03.041
  6. Kirienko AI, Yarovaya EB, Kutsenko VA, Orlovsky AA, Ivanov SV, Semenov MP, Semenov AM, Leontiev SG, Markin SS. Non-Immunogenic Staphylokinase vs Alteplase in Patients with Massive Pulmonary Embolism: the Protocol of a Multiple-Center Open-Label Randomized Trial FORPE. Journal of Venous Disorders. 2022;16(2):114-121. (In Russ.). https://doi.org/10.17116/flebo202216021114
  7. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing G, Harjola V, Huisman M, Humbert M, Jennings C, Jiménez D, Kucher N, Lang I, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano J, Galié N, Gibbs J, Aboyans V, Ageno W, Agewall S, Almeida A, Andreotti F, Barbato E, Bauersachs J, Baumbach A, Beygui F, Carlsen J, De Carlo M, Delcroix M, Delgado V, Subias P, Fitzsimons D, Gaine S, Goldhaber S, Gopalan D, Habib G, Halvorsen S, Jenkins D, Katus H, Kjellström B, Lainscak M, Lancellotti P, Lee G, Le Gal G, Messas E, Morais J, Petersen S, Petronio A, Piepoli M, Price S, Roffi M, Salvi A, Sanchez O, Shlyakhto E, Simpson I, Stortecky S, Thielmann M, Noordegraaf A, Becattini C, Bueno H, Geersing G, Harjola V, Huisman M, Humbert M, Jennings C, Jiménez D, Kucher N, Lang I, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, VanBelle E, LuisZamorano J, Windecker S, Aboyans V, Baigent C, Collet J, Dean V, Delgado V, Fitzsimons D, Gale C, Grobbee D, Halvorsen S, Hindricks G, Iung B, Jüni P, Katus H, Landmesser U, Leclercq C, Lettino M, Lewis B, Merkely B, Mueller C, Petersen S, Sonia Petronio A, Richter D, Roffi M, Shlyakhto E, Simpson I, Sousa-Uva M, Touyz R, Hammoudi N, Hayrapetyan H, Mascherbauer J, Ibrahimov F, Polonetsky O, Lancellotti P, Tokmakova M, Skoric B, Michaloliakos I, Hutyra M, Mellemkjaer S, Mostafa M, Reinmets J, Jääskeläinen P, Angoulvant D, Bauersachs J, Giannakoulas G, Zima E, Vizza C, Sugraliyev A, Bytyçi I, Maca A, Ereminiene E, Huijnen S, Xuereb R, Diaconu N, Bulatovic N, Asfalou I, Bosevski M, Halvorsen S, Sobkowicz B, Ferreira D, Petris A, Moiseeva O, Zavatta M, Obradovic S, Šimkova I, Radsel P, Ibanez B, Wikström G, Aujesky D, Kaymaz C, Parkhomenko A, Pepke-Zaba J. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603.  https://doi.org/10.1093/eurheartj/ehz405
  8. Smith SB, Geske JB, Kathuria P, Cuttica M, Schimmel DR, Courtney DM, Waterer GW, Wunderink RG. Analysis of National Trends in Admissions for Pulmonary Embolism. Chest. 2016;150(1):35-45.  https://doi.org/10.1016/j.chest.2016.02.638
  9. Turetz M, Sideris AT, Friedman OA, Triphathi N, Horowitz JM. Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism. Seminars in Interventional Radiology. 2018;35(2):2-98.  https://doi.org/10.1055/s-0038-1642036
  10. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Archives of Internal Medicine. 1998;158(6):585-593.  https://doi.org/10.1001/archinte.158.6.585
  11. Næss IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: A population-based study. Journal of Thrombosis and Haemostasis. 2007;5(4): 692-699.  https://doi.org/10.1111/j.1538-7836.2007.02450.x
  12. Aguilera CM, George, SJ, Johnson JL, Newby AC. Relationship between type IV collagen degradation, metalloproteinase activity and smooth muscle cell migration and proliferation in cultured human saphenous vein. Cardiovascular Research. 2003;58(3):679-688.  https://doi.org/10.1016/S0008-6363(03)00256-6
  13. Kirienko AI, Lebedev IS, Polyanko NI, Orekhov OO, Raksha AP, Turishcheva OO, Ivanchikova ES, Chumakova MA, Gavrilov SG. Pulmonary embolism in multifield hospital: results of autopsy study. Grekov’s Bulletin of Surgery. 2017;176(4):60-66. (In Russ.). https://doi.org/10.24884/0042-4625-2017-176-4-60-66
  14. Sazhin AV, Lebedev IS, Gavrilov SG, Nechay TV, Shishkina DI, Nechai VS, Efremova OI, Kirienko AI. Causes of Pulmonary Embolism According to Autopsies and Clinical Examination. Journal of Venous Disorders. 2019;13(3):202-210. (In Russ.). https://doi.org/10.17116/flebo201913031202
  15. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nature Reviews Immunology. 2013;13(1):34-45.  https://doi.org/10.1038/nri3345
  16. Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: Burden, mechanisms, and management. Thromb Haemost. 2017;117(2):219-230.  https://doi.org/10.1160/TH16-08-0615
  17. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary case-control study. Archives of Internal Medicine. 2002;160(6):809-815.  https://doi.org/10.1001/archinte.160.6.809
  18. Gloviczki P, Dalsing MC, Ekloef B, Lurie F, Wakefield TW, Gloviczki ML, Gloviczki M. Handbook of Venous and Lymphatic Disorders. Florida: CRC Press; 2017. https://doi.org/10.1201/9781315382449
  19. Engbers MJ, Karasu A, Blom JW, Cushman M, Rosendaal FR, van Hylckama Vlieg A. Clinical features of venous insufficiency and the risk of venous thrombosis in older people. British Journal of Haematology. 2015;171(3):417-423.  https://doi.org/10.1111/bjh.13579
  20. Goldhaber SZ, Savage DD, Garrison RJ, Castelli WP, Kannel WB, McNamara PM, Gherardi G, Feinleib M. Risk factors for pulmonary embolism. The Framingham study. The American Journal of Medicine. 1983;74(6):1023-1028. https://doi.org/10.1016/0002-9343(83)90805-7
  21. Erlikh AD, Barbarash OL, Berns SA, Duplyakov DV, Kondrashova AA, Cherkashin MA, Shmidt EA. Pulmonary embolism in cancer patients. Sirena register data. Journal of Venous Disorders. 2021;15(3):179-186. (In Russ.). https://doi.org/10.17116/flebo202115031179
  22. Ay C, Dunkler D, Marosi C, Chiriac AL, Vormittag R, Simanek R, Quehenberger P, Zielinski C, Pabinger I. Prediction of venous thromboembolism in cancer patients. Blood. 2010;116(24):5377-5382. https://doi.org/10.1182/blood-2010-02-270116
  23. Golovina VI, Seliverstov EI, An ES, Zolotukhin IA. Cancer-Associated Deep Vein Thrombosis: Insights from Randomized Trials and Real-Life Practice. Journal of Venous Disorders. 2022;16(2):156-163. (In Russ.). https://doi.org/10.17116/flebo202216021156
  24. Sciascia S, Baldovino S, Schreiber K, Solfietti L, Radin M, Cuadrado MJ, Menegatti E, Erkan D, Roccatello D. Thrombotic risk assessment in antiphospholipid syndrome: The role of new antibody specificities and thrombin generation assay. Clinical and Molecular Allergy. 2016;14:6.  https://doi.org/10.1186/s12948-016-0043-2
  25. Ge SQ, Tao X, Cai LS, Deng XY, Hwang MF, Wang CL. Associations of hormonal contraceptives and infertility medications on the risk of venous thromboembolism, ischemic stroke, and cardiovascular disease in women. Journal of Investigative Medicine. 2019;67(4):729-735.  https://doi.org/10.1136/jim-2018-000750
  26. Stillman RM, Chapa L, Stark ML, Malik LN, Keates JR, Sawyer PN. A ten year study of heparin therapy for thrombophlebitis in ambulatory patients. Surgery Gynecology and Obstetrics. 1977;145(2):193-197.  https://doi.org/10.1016/s0361-1124(78)80050-1
  27. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M, Geerts W, Kassis J, Desjardins L, Cusson J, Cruickshank M, Powers P, Brien W, Haley S, Willan A. A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis. New England Journal of Medicine. 1996;334(11):677-681.  https://doi.org/10.1056/nejm199603143341101
  28. Koopman MMW, Prandoni P, Piovella F, Ockelford PA, Brandjes DPM, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH, Bossuyt PMM, de Haes H, van den Belt AGM, Sagnard L, d’Azemar P, Büller HR. Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home. New England Journal of Medicine. 1996;334(11):682-687.  https://doi.org/10.1056/nejm199603143341102
  29. Harrison L, McGinnis J, Crowther M, Ginsberg J, Hirsh J. Assessment of outpatient treatment of deep-vein thrombosis with low- molecular-weight heparin. Archives of Internal Medicine. 1998;158(18):2001-2003. https://doi.org/10.1001/archinte.158.18.2001
  30. Frank D, Blättler W. Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: subjective and economic aspects. Schweizerische medizinische Wochenschrift. 1998;128(36):1328-1333.
  31. Labas P, Ohrádka B, Povinec P, Krizanová K, Cambal M. Ambulatory treatment of deep venous thrombosis using low-molecular heparin, compression and mobilization. Rozhledy v chirurgii: mesícník Ceskoslovenské chirurgické spolecnosti. 1999;78(10):529-532. 
  32. Tapson VF. Treatment of acute deep venous thrombosis and pulmonary embolism: Use of low molecular weight heparin. Seminars in Respiratory and Critical Care Medicine. 2000;21(6):547-535.  https://doi.org/10.1055/s-2000-13191
  33. Vinson DR, Berman DA. Outpatient treatment of deep venous thrombosis: A clinical care pathway managed by the emergency department. Annals of Emergency Medicine. 2001;37(3):251-258.  https://doi.org/10.1067/mem.2001.113703
  34. Othieno R, Okpo E, Forster R. Home versus in-patient treatment for deep vein thrombosis. Cochrane Database of Systematic Reviews. 2018;1(1): CD003076. https://doi.org/10.1002/14651858.CD003076.pub3
  35. Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, Kovacs J. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: A comparison of patient self-injection with homecare injection. Archives of Internal Medicine. 1998;158(16):1809-1812. https://doi.org/10.1001/archinte.158.16.1809
  36. Wells PS, Anderson DR, Rodger MA, Forgie MA, Florack P, Touchie D, Morrow B, Gray L, O’Rourke K, Wells G, Kovacs J, Kovacs MJ. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Archives of Internal Medicine. 2005;165(7):733-738.  https://doi.org/10.1001/archinte.165.7.733
  37. Segal JB, Bolger DT, Jenckes MW, Krishnan JA, Streiff MB, Eng J, Tamariz LJ, Bass EB. Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: A review of efficacy, safety, and costs. American Journal of Medicine. 2003;115(4):298-308.  https://doi.org/10.1016/S0002-9343(03)00326-7
  38. Beer JH, Burger M, Gretener S, Bernard-Bagattini S, Bounameaux H. Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients. Journal of Thrombosis and Haemostasis. 2003; 1(1):186-187.  https://doi.org/10.1046/j.1538-7836.2003.00005.x
  39. Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: Examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Archives of Internal Medicine. 2000;160(2):181-188.  https://doi.org/10.1001/archinte.160.2.181
  40. Peacock WF, Singer AJ. Reducing the hospital burden associated with the treatment of pulmonary embolism. Journal of Thrombosis and Haemostasis. 2019;17(5):720-736.  https://doi.org/10.1111/jth.14423
  41. Barco S, Lankeit M, Binder H, Schellong S, Christ M, Beyer-Westendorf J, Duerschmied D, Bauersachs R, Empen K, Held M, Schwaiblmair M, Fonseca C, Jiménez D, Becattini C, Quitzau K, Konstantinides S. Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: Rationale and design of the HoT-PE Trial. Thrombosis and Haemostasis. 2016;116(1):191-197.  https://doi.org/10.1160/TH16-01-0004
  42. Maughan BC, Frueh L, McDonagh MS, Casciere B, Kline JA. Outpatient Treatment of Low-risk Pulmonary Embolism in the Era of Direct Oral Anticoagulants: A Systematic Review. Academic Emergency Medicine. 2021;28(2):226-239.  https://doi.org/10.1111/acem.14108
  43. Piran S, Le Gal G, Wells PS, Gandara E, Righini M, Rodger MA, Carrier M. Outpatient treatment of symptomatic pulmonary embolism: A systematic review and meta-analysis. Thrombosis Research. 2013;132(5):515-519.  https://doi.org/10.1016/j.thromres.2013.08.012
  44. Lozano F, Trujillo-Santos J, Barrón M, Gallego P, Babalis D, Santos M, Falgá C, Monreal M. Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs. Journal of Vascular Surgery. 2014;59(5):1362-1367. https://doi.org/10.1016/j.jvs.2013.11.091
  45. Hull RD. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings. Thrombosis and Haemostasis. 2008;99(3):502-510.  https://doi.org/10.1160/TH07-08-0500
  46. Merli GJ, Kearon C. Treating Acute Pulmonary Embolism: Outpatient or Inpatient or Somewhere in between. Thrombosis Research. 2008;123(SUPPL. 1):22-28.  https://doi.org/10.1016/j.thromres.2008.08.014
  47. Otero R, Jiménez D. Pulmonary embolism at home. European Respiratory Journal. 2008;31(3):686-687.  https://doi.org/10.1183/09031936.00143907
  48. Janjua M, Badshah A, Matta F, Danescu LG, Yaekoub AY, Stein PD. Treatment of acute pulmonary embolism as outpatients or following early discharge — A systematic review. Thrombosis and Haemostasis. 2008;100(5):756-761.  https://doi.org/10.1160/TH08-05-0319
  49. Trujillo-Santos J, Lozano F, Lorente MA, Adarraga D, Hirmerova J, Toro JD, Mazzolai L, Barillari G, Barrón M, Monreal M, Alcalde M, Andújar V, Arcelus JI, Barba R, Barrón-Andrés B, Bascuñana J, Blanco-Molina A, Bueso T, Casado I, Serrano JC. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs. American Journal of Medicine. 2015;128(1):90.e9-15.  https://doi.org/10.1016/j.amjmed.2014.08.023
  50. Palas M, Silva BV, Jorge C, Almeida AG, Pinto FJ, Caldeira D. The Accuracy of Hestia and Simplified PESI to Predict the Prognosis in Pulmonary Embolism: Systematic Review with Meta-analysis. TH Open. 2022;6(4):e347-e353. https://doi.org/10.1055/a-1942-2526
  51. Roy PM, Penaloza A, Hugli O, Klok FA, Arnoux A, Elias A, Couturaud F, Joly LM, Lopez R, Faber LM, Daoud-Elias M, Planquette B, Bokobza J, Viglino D, Schmidt J, Juchet H, Mahe I, Mulder F, Bartiaux M, Cren R, Moumneh T, Quere I, Falvo N, Montaclair K, Douillet D, Steinier C, Hendriks SV, Benhamou Y, Szwebel TA, Pernod G, Dublanchet N, Lapebie FX, Javaud N, Ghuysen A, Sebbane M, Chatellier G, Meyer G, Jimenez D, Huisman MV, Sanchez O. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: The HOME-PE randomized trial. European Heart Journal. 2021;42(33):3146-3157. https://doi.org/10.1093/eurheartj/ehab373
  52. Zondag W, Mos ICM, Creemers-Schild D, Hoogerbrugge ADM, Dekkers OM, Dolsma J, Eijsvogel M, Faber LM, Hofstee HMA, Hovens MMC, Jonkers GJPM, van Kralingen KW, Kruip MJHA, Vlasveld T, de Vreede MJM, Huisman MV. Outpatient treatment in patients with acute pulmonary embolism: The Hestia Study. Journal of Thrombosis and Haemostasis. 2011;9(8):1500-1507. https://doi.org/10.1111/j.1538-7836.2011.04388.x
  53. Donzé J, Le Gal G, Fine MJ, Roy PM, Sanchez O, Verschuren F, Cornuz J, Meyer G, Perrier A, Righini M, Aujesky D. Prospective validation of the Pulmonary Embolism Severity Index: A clinical prognostic model for pulmonary embolism. Thrombosis and Haemostasis. 2008;100(5):943-948.  https://doi.org/10.1160/TH08-05-0285
  54. Elias A, Mallett S, Daoud-Elias M, Poggi JN, Clarke M. Prognostic models in acute pulmonary embolism: A systematic review and meta-analysis. BMJ Open. 2016;6(4):e010324. https://doi.org/10.1136/bmjopen-2015-010324
  55. Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Archives of Internal Medicine. 2010;170(15):1383-1389. https://doi.org/10.1001/archinternmed.2010.199
  56. Sam A, Sánchez D, Gómez V, Wagner C, Kopecna D, Zamarro C, Moores L, Aujesky D, Yusen R, Jiménez Castro D. The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism. European Respiratory Journal. 2011;37(4):762-766.  https://doi.org/10.1183/09031936.00070110
  57. Fermann GJ, Erkens PMG, Prins MH, Wells PS, Pap ÁF, Lensing AWA. Treatment of pulmonary embolism with rivaroxaban: Outcomes by simplified pulmonary embolism severity index score from a post hoc analysis of the einstein pe study. Academic Emergency Medicine. 2015;22(3):299-307.  https://doi.org/10.1111/acem.12615
  58. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ. Derivation and validation of a prognostic model for pulmonary embolism. American Journal of Respiratory and Critical Care Medicine. 2005;172(8):1041-1046. https://doi.org/10.1164/rccm.200506-862OC
  59. Weeda ER, Kohn CG, Peacock WF, Fermann GJ, Crivera C, Schein JR, Coleman CI. External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality. Clinical and Applied Thrombosis/Hemostasis. 2017;23(7):769-774.  https://doi.org/10.1177/1076029616651147
  60. Barco S, Mahmoudpour SH, Planquette B, Sanchez O, Konstantinides SV, Meyer G. Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: A systematic review and meta-analysis. European Heart Journal. 2019;40(11):902-910.  https://doi.org/10.1093/eurheartj/ehy873
  61. Hendriks SV, Lankeit M, den Exter PL, Zondag W, Brouwer R, Eijsvogel M, Grootenboers MJ, Faber LM, Heller-Baan R, Hofstee HMA, Iglesias del Sol A, Mairuhu ATA, Melissant CF, Peltenburg HG, van de Ree MA, Serné EH, Konstantinides S, Klok FA, Huisman MV. Uncertain Value of High-sensitive Troponin T for Selecting Patients with Acute Pulmonary Embolism for Outpatient Treatment by Hestia Criteria. Academic Emergency Medicine. 2020;27(10):1043-1046. https://doi.org/10.1111/acem.13943
  62. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033-3069. https://doi.org/10.1093/eurheartj/ehu283
  63. Mastroiacovo D, Dentali F, di Micco P, Maestre A, Sahuquillo DJJC, Verhamme P, Fidalgo Á, López-Sáez JB, Skride A, Soler S, Monreal M, Adarraga MD, Aibar MA, Alfonso M, Álvarez F, Arcelus JI, Ballaz A, Baños P, Barba R, Mazzolai L. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: Analysis from the RIETE registry. European Respiratory Journal. 2019;53(2):1801677. https://doi.org/10.1183/13993003.01677-2018
  64. Prandoni P, Lensing AWA, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100(10):3484-3488. https://doi.org/10.1182/blood-2002-01-0108
  65. Vanni S, Becattini C, Nazerian P, Bova C, Stefanone VT, Cimini LA, Viviani G, Caviglioli C, Sanna M, Pepe G, Grifoni S. Early discharge of patients with pulmonary embolism in daily clinical practice: A prospective observational study comparing clinical gestalt and clinical rules. Thrombosis Research. 2018;167:37-43.  https://doi.org/10.1016/j.thromres.2018.05.008
  66. Mahler SA, Riley RF, Hiestand BC, Russell GB, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Elliott SB, Herrington DM, Burke GL, Miller CD. The HEART Pathway Randomized Trial: Identifying Emergency Department Patients with Acute Chest Pain for Early Discharge. Circulation: Cardiovascular Quality and Outcomes. 2015;8(2):195-203.  https://doi.org/10.1161/CIRCOUTCOMES.114.001384
  67. Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, Sidney S. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558): 283-292.  https://doi.org/10.1016/S0140-6736(07)60150-0
  68. Lim WS, Van Der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax. 2003;58(5):377-382.  https://doi.org/10.1136/thorax.58.5.377
  69. Watson NW, Carroll BJ, Krawisz A, Schmaier A, Secemsky EA. Trends in Discharge Rates for Acute Pulmonary Embolism in U.S. Emergency Departments. Annals of Internal Medicine. 2024;177(2):134-143.  https://doi.org/10.7326/M23-2442
  70. Lobastov K, Vorontsova A, Bargandzhiya A, Schastlivtsev I, Laberko L. Outpatient Treatment for Deep Vein Thrombosis with Rivaroxaban: A Single-Center Experience. Journal of Venous Disorders. 2020;14(2):99-106.  https://doi.org/10.17116/flebo20201402199
  71. Seliverstov EI, Lobastov KV, Ilyukhin EA, Apkhanova TV, Akhmetzyanov RV, Akhtyamov IF, Barinov VE, Bakhmetiev AS, Belov MV, Bobrov SA, Bozhkova SA, Bredikhin RA, Bulatov VL, Vavilova TV, Vardanyan AV, Vorobiev NA, Gavrilov EK, Gavrilov SG, Golovina VI, Gorin AS, Dzhenina OV, Dianov SV, Efremova OI, Zhukovets VV, Zamyatin MN, Ignatiev IA, Kalinin RE, Kamaev AA, Kaplunov OA, Karimova GN, Karpenko AA, Kasimova AR, Katelnitskaya OV, Katelnitsky II, Katorkin SE, Knyazev RI, Konchugova TV, Kopenkin SS, Koshevoy AP, Kravtsov PF, Krylov AYu, Kulchitskaya DB, Laberko LA, Lebedev IS, Malanin DA, Matyushkin AV, Mzhavanadze ND, Moiseev SV, Mushtin NE, Nikolaeva MG, Pelevin AV, Petrikov AS, Piradov MA, Pikhanova ZhM, Poddubnaya IV, Porembskaya OYa, Potapov MP, Pyregov AV, Rachin AP, Rogachevsky OV, Ryabinkina YuV, Sapelkin SV, Sonkin IN, Soroka VV, Sushkov SA, Schastlivtsev IV, Tikhilov RM, Tryakin AA, Fokin AA, Khoronenko VE, Khruslov MV, Tsaturyan AB, Tsed AN, Cherkashin MA, Chechulova AV, Chuiko SG, Shimanko AI, Shmakov RG, Yavelov IS, Yashkin MN, Kirienko AI, Zolotukhin IA, Stoyko YuM, Suchkov IA. Prevention, Diagnostics and Treatment of Deep Vein Thrombosis. Russian Experts Consensus. Journal of Venous Disorders. 2023;17(3):152-296. (In Russ.). https://doi.org/10.17116/flebo202317031152
  72. Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, Lake E, Murin S, Vintch JRE, Wells PS, Moores LK. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):e545-e608. https://doi.org/10.1016/j.chest.2021.07.055

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.